Compare JKS & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JKS | MNKD |
|---|---|---|
| Founded | 2006 | 1991 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2010 | 2004 |
| Metric | JKS | MNKD |
|---|---|---|
| Price | $19.19 | $3.92 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $24.80 | $8.69 |
| AVG Volume (30 Days) | 791.5K | ★ 4.9M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | ★ 6.04% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,966,000.00 |
| Revenue This Year | N/A | $35.81 |
| Revenue Next Year | $14.60 | $11.89 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $17.37 | $2.23 |
| 52 Week High | $31.88 | $6.51 |
| Indicator | JKS | MNKD |
|---|---|---|
| Relative Strength Index (RSI) | 39.91 | 63.23 |
| Support Level | $17.37 | $3.30 |
| Resistance Level | $26.68 | $3.94 |
| Average True Range (ATR) | 1.24 | 0.23 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 32.74 | 80.13 |
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), the Americas, Europe, Asia Pacific, and the Rest of the world.
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.